BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹335 Cr | ₹320 Cr | ₹311 Cr | ₹261 Cr | ₹240 Cr |
What is the latest Total Liabilities ratio of BAL PHARMA ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹335 Cr |
Mar2024 | ₹320 Cr |
Mar2023 | ₹311 Cr |
Mar2022 | ₹261 Cr |
Mar2021 | ₹240 Cr |
How is Total Liabilities of BAL PHARMA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹335 Cr | 4.83 | |
Mar2024 | ₹320 Cr | 2.84 | |
Mar2023 | ₹311 Cr | 19.37 | |
Mar2022 | ₹261 Cr | 8.52 | |
Mar2021 | ₹240 Cr | - |
Compare Total Liabilities of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹132.2 Cr | -2.8% | -8% | -35.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,567.0 Cr | 0.5% | 4.6% | -18.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,601.0 Cr | -3.2% | -6.7% | 4.4% | Stock Analytics | |
CIPLA | ₹122,284.0 Cr | 0.3% | -3.5% | -10.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,593.0 Cr | 0.9% | -0.6% | 3.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,014.0 Cr | -2.2% | -0.9% | -9.4% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -2.8% |
-8% |
-35.4% |
SENSEX | -0.9% |
0.8% |
-5.7% |
You may also like the below Video Courses